Targeting type 1 IFN in immune-mediated inflammatory disease
Building on decades of research, AstraZeneca are starting to unravel complex inflammatory cell signalling pathways and uncover key drivers that cause an imbalance in immune-mediated diseases.
Date:
12 January 2023, 12:00
Venue:
Institute of Developmental and Regenerative Medicine (IDRM) IMS-Tetsuya Nakamura Building, Old Road Campus, Roosevelt Dr, Headington, Oxford OX3 7TY and Zoom
Speaker:
Dr Hussein Al-Mossawi (AstraZeneca)
Organising department:
Medical Sciences Office
Organisers:
Sheena Lee (MSD Business Partnerships Office),
Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address:
sheena.lee@medsci.ox.ac.uk
Host:
Dr Charlotte Bell (University of Oxford)
Part of:
Industry Insight Seminar Series
Booking required?:
Required
Booking url:
https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost:
Free
Audience:
Members of the University of Oxford and the Biotech/Pharma industry
Editor:
Sheena Lee
